{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:20:57Z","timestamp":1773220857223,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":5739,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1093\/annonc\/mdh137","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T13:34:18Z","timestamp":1079703258000},"page":"610-612","source":"Crossref","is-referenced-by-count":26,"title":["Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2"],"prefix":"10.1016","volume":"15","author":[{"given":"O.","family":"Merimsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Weitzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nehushtan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rubinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ben-Shahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Biran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Katsenelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mermershtein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Loven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Karminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Matcejevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Inbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh137_bb0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G","article-title":"Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases","volume":"28","author":"Skinner","year":"1971","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh137_bb0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-5347(17)62331-0","article-title":"The results of radical nephrectomy for renal cell carcinoma","volume":"101","author":"Robson","year":"1969","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mdh137_bb0020","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.1999.17.8.2530","article-title":"Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma","volume":"17","author":"Motzer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh137_bb0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM199804303381805","article-title":"Recombinant human interleukin-2, recombinant human interferon \u03b1-2a, or both in metastatic renal cell carcinoma","volume":"338","author":"Negrier","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh137_bb0030","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jama.1994.03510360033032","article-title":"The treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2","volume":"271","author":"Rosenberg","year":"1994","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdh137_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(98)03544-2","article-title":"Interferon-\u03b1 and survival in metastatic renal carcinoma: early results of a randomised controlled trial","volume":"353","author":"Ritchie","year":"1999","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh137_bb0040","first-page":"286","article-title":"Interferon-\u03b1 and survival in renal cell cancer","volume":"76","author":"Fossa","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh137_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01372560","article-title":"Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon \u03b1 in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment","volume":"120","author":"Huland","year":"1994","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1093\/annonc\/mdh137_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1442-2042.1997.tb00205.x","article-title":"Inhalation of interleukin-2 combined with subcutaneous administration of interferon for the treatment of pulmonary metastases from renal cell carcinoma","volume":"4","author":"Nakamoto","year":"1997","journal-title":"Int J Urol"},{"key":"10.1093\/annonc\/mdh137_bb0055","doi-asserted-by":"crossref","unstructured":"Huland E, Heinzer H, Mir TS, Huland H. Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience. Cancer J Sci Am1997; 3 (Suppl 1): S98\u2013S105.","DOI":"10.1016\/S0959-8049(97)84795-8"},{"key":"10.1093\/annonc\/mdh137_bb0060","doi-asserted-by":"crossref","unstructured":"Putnam JB. New and evolving treatment methods for pulmonary metastases. Semin Thorac Cardiovasc Surg2002 14:49-56.","DOI":"10.1053\/stcs.2002.32069"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdh137_bb0065","first-page":"S104","article-title":"Overview of interleukin-2 inhalation therapy","volume":"6","author":"Huland","year":"2000","journal-title":"Cancer J Sci Am"},{"key":"10.1093\/annonc\/mdh137_bb0070","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1200\/JCO.1995.13.3.688","article-title":"Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy","volume":"13","author":"Fyfe","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh137_bb0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1200\/JCO.20.1.302","article-title":"Phase II trial of thalidomide for patients with advanced renal cell carcinoma","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh137_bb0080","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1200\/JCO.2003.03.057","article-title":"National Cancer Institute of Canada\u2013Clinical Trials Group. Phase II study of troxacitabine (BCH-4556) in patients with advanced and\/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada\u2013Clinical Trials Group","volume":"21","author":"Townsley","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh137_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1200\/JCO.2001.19.1.265","article-title":"Clinical trial designs for cytostatic agents: are new approaches needed?","volume":"19","author":"Korn","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419453003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419453003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/4\/610\/547249\/mdh137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T10:58:47Z","timestamp":1582196327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419453003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0923753419453003"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh137","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}